Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in J Med Virol

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    July 2017
  1. WEHMEYER MH, Ingiliz P, Christensen S, Hueppe D, et al
    Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: results from the multicenter German hepatitis C cohort (GECCO-03).
    J Med Virol. 2017 Jul 15. doi: 10.1002/jmv.24903.
    PubMed     Text format     Abstract available


  2. LISBOA NETO G, M Malta F, Gomes-Gouvea MS, F Noble C, et al
    CHARACTERIZATION OF CLINICAL PREDICTORS OF NATURALLY OCCURRING NS3/NS4A PROTEASE POLYMORPHISM IN GENOTYPE 1 HEPATITIS C VIRUS MONO AND HIV CO-INFECTED PATIENTS.
    J Med Virol. 2017 Jul 12. doi: 10.1002/jmv.24900.
    PubMed     Text format     Abstract available


  3. MARRA E, King A, van Logchem E, van der Weele P, et al
    Anal HPV 16 and 18 viral load: a comparison between HIV-negative and HIV-positive MSM and association with persistence.
    J Med Virol. 2017 Jul 12. doi: 10.1002/jmv.24898.
    PubMed     Text format     Abstract available


    June 2017
  4. GANTNER P, Melard A, Damond F, Delaugerre C, et al
    Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies.
    J Med Virol. 2017 Jun 15. doi: 10.1002/jmv.24874.
    PubMed     Text format     Abstract available


  5. TRABAUD MA, Icard V, Ramiere C, Tardy JC, et al
    Comparison of HIV-1 drug-resistance genotyping by Ultra-Deep Sequencing and Sanger sequencing using clinical samples.
    J Med Virol. 2017 Jun 7. doi: 10.1002/jmv.24872.
    PubMed     Text format     Abstract available


    May 2017
  6. KUANG WD, Zhou YH, Zhong P, Zhang C, et al
    Amino Acids at Positions 3, 168 and 169 are Associated with the Ability of Nef Proteins from HIV-1 CRF01_AE to Downmodulate CD4.
    J Med Virol. 2017 May 13. doi: 10.1002/jmv.24851.
    PubMed     Text format     Abstract available


  7. LINS L, Farias E, Brites-Alves C, Torres A, et al
    Increased expression of CD38 and HLADR in HIV-infected patients with oral lesion.
    J Med Virol. 2017 May 13. doi: 10.1002/jmv.24852.
    PubMed     Text format     Abstract available


  8. DOS SANTOS MIMA, Rugiere SP, Stocker A, Schinoni MI, et al
    Mutations Associated With Drug Resistance and Prevalence of Vaccine Escape Mutations In Patients With Chronic Hepatitis B Infection.
    J Med Virol. 2017 May 13. doi: 10.1002/jmv.24853.
    PubMed     Text format     Abstract available


    April 2017
  9. BLACKARD JT, Ma G, Welge JA, Taylor LE, et al
    Cytokine/chemokine expression associated with Human Pegivirus (HPgV) infection in women with HIV.
    J Med Virol. 2017 Apr 29. doi: 10.1002/jmv.24836.
    PubMed     Text format     Abstract available


  10. JABLONOWSKA E, Pulik P, Kalinowska A, Gasiorowski J, et al
    "Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients".
    J Med Virol. 2017 Apr 8. doi: 10.1002/jmv.24826.
    PubMed     Text format     Abstract available


  11. DUBE MANDISHORA RS, Christiansen IK, Chin'ombe N, Duri K, et al
    Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe.
    J Med Virol. 2017 Apr 8. doi: 10.1002/jmv.24825.
    PubMed     Text format     Abstract available


    March 2017
  12. HUSAIN M, Sharma U, Gupta P, Singhal M, et al
    Comparative genetic variability in HIV-1 subtype C nef gene in early age groups of infants.
    J Med Virol. 2017 Mar 31. doi: 10.1002/jmv.24820.
    PubMed     Text format     Abstract available


  13. SNELL LB, Smith C, Chaytor S, McRae K, et al
    Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis.
    J Med Virol. 2017 Mar 31. doi: 10.1002/jmv.24818.
    PubMed     Text format     Abstract available


  14. COMAR M, Seraceni S, Colli C, Luska V, et al
    Chlamydia trachomatis and HPV co-infections in HIV negative men from a multi-ethnic area of Northern Italy at high prevalence of cervical malignancies.
    J Med Virol. 2017 Mar 18. doi: 10.1002/jmv.24811.
    PubMed     Text format     Abstract available


  15. LIU Z, Fang Q, Zhou S, Minhas V, et al
    Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China.
    J Med Virol. 2017 Mar 2. doi: 10.1002/jmv.24804.
    PubMed     Text format     Abstract available


    February 2017
  16. AUGUSTO A, Augusto O, Taquimo A, Nhachigule C, et al
    First description of HTLV-1/2 seroprevalence in HIV-infected inmates in Mozambique.
    J Med Virol. 2017 Feb 27. doi: 10.1002/jmv.24801.
    PubMed     Text format     Abstract available


  17. SAMLEERAT T, Hongjaisee S, Phiayura P, Sirirungsi W, et al
    HIV-1 coreceptor usage in perinatally infected Thai children.
    J Med Virol. 2017 Feb 15. doi: 10.1002/jmv.24790.
    PubMed     Text format     Abstract available


  18. ZHANG L, Wang B, Liang Y, Feng Y, et al
    Phylogenetic characteristics of HIV-1 among travelers entering China from Myanmar: A retrospective study.
    J Med Virol. 2017 Feb 15. doi: 10.1002/jmv.24786.
    PubMed     Text format     Abstract available


  19. FLORES GL, Cruz HM, Marques VA, Villela-Nogueira CA, et al
    Performance of anti-HCV testing in dried blood spots and saliva according to HIV status.
    J Med Virol. 2017 Feb 6. doi: 10.1002/jmv.24777.
    PubMed     Text format     Abstract available


    January 2017
  20. GRANDAL M, Pernas B, Marino A, Alvarez H, et al
    Characterization of chronic HCV infection in Northwest Spain: Impact of the treatment strategic plan of the Spanish National Health Service on HCV cure.
    J Med Virol. 2017 Jan 12. doi: 10.1002/jmv.24766.
    PubMed     Text format     Abstract available


    December 2016
  21. PAIVA A, Smid J, Haziot ME, Assone T, et al
    High risk of heterosexual transmission of human T-cell lymphotropic virus type 1 infection in Brazil.
    J Med Virol. 2016 Dec 9. doi: 10.1002/jmv.24745.
    PubMed     Text format     Abstract available


  22. KODANI M, Ahmed N, Tejada-Strop A, Poe A, et al
    Variability in the performance characteristics of IgG anti-HEV assays and its impact on reliability of seroprevalence rates of hepatitis E.
    J Med Virol. 2016 Dec 6. doi: 10.1002/jmv.24741.
    PubMed     Text format     Abstract available


  23. WANG B, Liang Y, Wang Y, Feng Y, et al
    HIV prevalence and phylogenetic characteristics among entry travelers in Xishuangbanna prefecture, Yunnan Province, between 2003 and 2012.
    J Med Virol. 2016 Dec 6. doi: 10.1002/jmv.24740.
    PubMed     Text format     Abstract available


    November 2016
  24. SHARMA AL, Singh TR, Devi KR, Singh LS, et al
    Molecular epidemiology of HIV-1 among the HIV infected people of Manipur, Northeastern India: Emergence of unique recombinant forms.
    J Med Virol. 2016 Nov 21. doi: 10.1002/jmv.24738.
    PubMed     Text format     Abstract available


  25. SALEMI JL, Spooner KK, Mejia de Grubb MC, Aggarwal A, et al
    National trends of hepatitis B and C during pregnancy across sociodemographic, behavioral, and clinical factors, United States, 1998-2011.
    J Med Virol. 2016 Nov 2. doi: 10.1002/jmv.24725.
    PubMed     Text format     Abstract available


    October 2016
  26. WANG N, Li Y, Han Y, Xie J, et al
    HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy.
    J Med Virol. 2016 Oct 28. doi: 10.1002/jmv.24723.
    PubMed     Text format     Abstract available


  27. LIU Z, Fang Q, Zuo J, Wang J, et al
    High seroprevalence of human herpesvirus 8 and herpes simplex virus 2 infections in men who have sex with men in Shanghai, China.
    J Med Virol. 2016 Oct 21. doi: 10.1002/jmv.24718.
    PubMed     Text format     Abstract available


    September 2016
  28. JOGEDA EL, Huik K, Pauskar M, Kallas E, et al
    The prevalence and genotypes of GBV-C and its associations with HIV infection among persons who inject drugs in Eastern Europe.
    J Med Virol. 2016 Sep 7. doi: 10.1002/jmv.24683.
    PubMed     Text format     Abstract available


  29. SLAVOV SN, Otaguiri KK, Smid J, de Oliveira AC, et al
    Human parvovirus 4 prevalence among HTLV-1/2 infected individuals in Brazil.
    J Med Virol. 2016 Sep 2. doi: 10.1002/jmv.24673.
    PubMed     Text format     Abstract available


    August 2016
  30. WU S, Yan P, Yang T, Wang Z, et al
    Epidemiological profile and risk factors of HIV and HBV/HCV co-infection in Fujian Province, southeastern China.
    J Med Virol. 2016 Aug 23. doi: 10.1002/jmv.24666.
    PubMed     Text format     Abstract available


    July 2016
  31. DE PASCHALE M, Manco MT, Belvisi L, Cagnin D, et al
    Evaluation of LIAISON(R) XL system for HBsAg, and anti-HCV and anti-HIV/Ag p24.
    J Med Virol. 2016 Jul 28. doi: 10.1002/jmv.24648.
    PubMed     Text format     Abstract available


  32. VARMAZYAR S, Shoja Z, Kakavand-Ghalehnoei R, Shahmahmoodi S, et al
    Molecular typing of human herpesvirus 8 among HIV positive in comparison to HIV-negative individuals in Iran.
    J Med Virol. 2016 Jul 27. doi: 10.1002/jmv.24644.
    PubMed     Text format     Abstract available


  33. BAUDI I, Iijima S, Chin'ombe N, Mtapuri-Zinyowera S, et al
    Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe.
    J Med Virol. 2016 Jul 26. doi: 10.1002/jmv.24641.
    PubMed     Text format     Abstract available


  34. OLESEN TB, Mwaiselage J, Iftner T, Kahesa C, et al
    Risk factors for genital Human Papillomavirus among men in Tanzania.
    J Med Virol. 2016 Jul 12. doi: 10.1002/jmv.24627.
    PubMed     Text format     Abstract available


  35. SADEGHI A, Shirvani-Dastgerdi E, Tacke F, Yagmur E, et al
    HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg.
    J Med Virol. 2016 Jul 6. doi: 10.1002/jmv.24623.
    PubMed     Text format     Abstract available


    June 2016
  36. KAMORI D, Hasan Z, Ohashi J, Kawana-Tachikawa A, et al
    Identification of two unique naturally occurring Vpr sequence polymorphisms associated with clinical parameters in HIV-1 chronic infection.
    J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24612.
    PubMed     Text format     Abstract available


  37. DIMONTE S
    Different HIV-1 env frames: gp120 and ASP (antisense protein) biosynthesis, and theirs co-variation tropic amino acid signatures in X4- and R5-viruses.
    J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24611.
    PubMed     Text format     Abstract available


  38. ARALAGUPPE SG, Winner D, Singh K, Sarafianos SG, et al
    Increased replication capacity following evolution of PYxE insertion in gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa.
    J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24610.
    PubMed     Text format     Abstract available


  39. BEGHIN JC, Ruelle J, Sokal E, Bachy A, et al
    Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus-1 living in a resource-limited setting of Kwazulu-Natal.
    J Med Virol. 2016 Jun 13. doi: 10.1002/jmv.24598.
    PubMed     Text format     Abstract available


    May 2016
  40. ROSCA A, Anton G, Botezatu A, Temereanca A, et al
    miR-29a associates with viro-immunological markers of HIV infection in treatment experienced patients.
    J Med Virol. 2016 May 27. doi: 10.1002/jmv.24586.
    PubMed     Text format     Abstract available


  41. PERNAS B, Grandal M, Tabernilla A, Cid P, et al
    Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain.
    J Med Virol. 2016 May 24. doi: 10.1002/jmv.24585.
    PubMed     Text format     Abstract available


  42. MICHELINI Z, Galluzzo CM, Pirillo MF, Francisci D, et al
    HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy.
    J Med Virol. 2016 May 19. doi: 10.1002/jmv.24581.
    PubMed     Text format     Abstract available


  43. MOTA LD, Nishiya AS, Finger-Jardim F, Barral MF, et al
    Prevalence of human pegivirus (HPgV) infection in patients carrying HIV-1C or non-C in southern Brazil.
    J Med Virol. 2016 May 12. doi: 10.1002/jmv.24574.
    PubMed     Text format     Abstract available


  44. ALBERTI A, Lacoin L, Morais E, Lefevre C, et al
    A literature review of the distribution of hepatitis C virus genotypes across Europe.
    J Med Virol. 2016 May 12. doi: 10.1002/jmv.24573.
    PubMed     Text format     Abstract available


  45. ZHANG L, Tian Y, Wen Z, Zhang F, et al
    Asialoglycoprotein receptor facilitates infection of PLC/PRF/5 cells by HEV through interaction with ORF2.
    J Med Virol. 2016 May 7. doi: 10.1002/jmv.24570.
    PubMed     Text format     Abstract available


    April 2016
  46. LI L, Sun G, Zhong P, Han J, et al
    HIV-1 Thai B strain has spread out of former plasma donors into general population through sexual contact in Henan, China.
    J Med Virol. 2016;88:614-21.
    PubMed     Text format     Abstract available


    January 2016
  47. BOKHARAEI-SALIM F, Keyvani H, Esghaei M, Zare-Karizi S, et al
    Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.
    J Med Virol. 2016 Jan 14. doi: 10.1002/jmv.24474.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: